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PAPILLOEDEMA 
 
INTRODUCTION 
 
 The etiological diagnosis and management of  papilloedema 
is one of the most fascinating and perplexing problems of Neuro 
ophthalmology.  Papilloedema is one of the most common 
conditions an ophthalmologist comes across in  routine clinical 
practice.   The ophthalmologist has a vital role in differentiating 
papilloedema from pseudo papilloedema,  in confirming the 
diagnosis and in advising the time of surgery and in giving the 
prognosis as far as vision is concerned.  In this study an attempt 
has been made to study papilloedema in all its aspects. 
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AIM OF THE STUDY 
 
1. To study the different etiologies of papilloedema in a 
tertiary level  hospital.   
 
2. To study the progression of papilloedema during the course 
of disease. 
 
3.  To find out the associated systemic causes. 
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REVIEW OF LITERATURE 
 
 Parson in 1908, first applied the term "papilloedema" to 
swellings of the optic disc that exceeded two diopters and were 
associated with increased intra cranial pressure. 
 The German expression "Struungspapille" is used in this 
context.  Lesser degrees of disc swelling with increased intra 
cranial pressure were designated as Papilloderm (Uthoff). Hubler 
recommends that the term Struungspapille be extended to 
encompass all stages of disc swelling caused by increased intra 
cranial pressure. 
 In 1911, Paton and Holmes made the first detailed 
morphologic studies of  disc swelling and provided definite 
description of non inflammatory "passive oedema" encountered 
in patients with normal vision and increased intra cranial 
pressure.  For these cases, they used Parson’s term 
"Papilloedema" and the term "Optic neuritis" to swelling of the 
disc associated with local inflammation and loss of vision. 
 The term "Papilloedema" is used for all forms of disc 
swelling that result from increased intra cranial pressure.  And  
the unrestricted  expression "oedema" of the optic disc or "disc 
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oedema" to all other forms of disc swelling of local or systemic 
etiology that do not significantly affect vision. 
 It is nearly always bilateral, although it may be 
asymmetrical all patients with papilloedema should be suspected 
of having an intra cranial mass unless proved otherwise.  
However not all patients with raised intra cranial pressure will 
necessarily develop papilloedema.  Tumours of cerebral 
hemispheres tend to produce papilloedema later than those in 
the posterior fossa.  Patient with a history of previous 
papilloedema may develop a substantial increase in intra cranial 
pressure but fail to re-develop papilloedema because of glial 
scarring of the optic nerve head. 
 
DEFINITION 
 Papilloedema is defined "as bilateral passive non 
inflammatory edema of the optic disc due to raised intracranial 
pressure which is almost always bilateral and without visual 
deficit". 
 Normal CSF pressure in the lateral recumbent position 
varies between 100 – 250 mm of H2O.  Normal opening pressure 
of CSF on lumbar puncture is  < 80mm H2O in infants, < 90mm 
H2O in children and < 210mm  H2O in adults. 
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ANATOMY OF OPTIC NERVE HEAD 
(a) REGIONS: 
 The optic nerve head consists of four regions 
i) Superficial nerve fibre layer 
ii) Prelaminar region 
iii) Laminar region 
iv) Retro laminar region. 
i) Superficial nerve fibre layer  
 This part is essentially composed of axonal bundles of 
nerve fibres of the retina (94%) which converge on the optic disc 
and astrocytes (5%).  The optic disc is covered by a thin layer of 
astrocytes, the internal limiting membrane of   Elsching which 
separates it from the vitreous and is continuous with the 
internal limiting membrane of retina.  When the central portion 
of this membrane is thickened it is referred to as the central 
meniscus of Kuhnt2. 
 All the layers of retina, apart  from the nerve fibre layer 
(NFL)  near the optic nerve, are separated from it by a partial rim 
of glial tissue called the intermediate tissue of Kuhnt. 
ii) Prelaminar region: 
 The predominant structures at this level are neurons and a 
significantly increased quantity of astroglial tissue.  The border 
tissue of Jacoby separates the nerve from choroid. 
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iii) Laminar region: 
 It is a fibrillar sieve like structure made up of fenestrated 
sheets of scleral connective tissue lined by glial tissue.   The 
bundles of optic nerve fibres leave the eye through these 
fenestrations. 
iv) Retro laminar region: 
 This area is characterized by a decrease in astrocytes and 
the acquisition of myelin that is supplied by oligodentrocytes.  
The addition of myelin sheath nearly doubles the diameter of 
optic nerve from 1.5mm to 3.0mm as it passes through sclera. 
(b) BLOOD SUPPLY: 
 (i) Surface nerve fibre layer is mainly supplied by the 
capillaries derived from the retinal arterioles, which anastamose 
with vessels of the prelaminar region.  Occasionally a ciliary 
derived vessel from the pre laminar region may enlarge to form 
the cilioretinal artery2. 
(ii) The prelaminar region is supplied by vessels of ciliary 
region.  These vessels are primarily derived from the 
peripapillary choroidal system or from separate branches of the 
short posterior ciliary arteries. 
 (iii) The lamina cribrosa region is supplied by the ciliary 
vessels which are derived from the short posterior ciliary arteries 
and arterial circle of Zinn-Haller. 
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 (iv)  The retro laminar region is supplied by both the ciliary 
and retinal circulation with the former coming from recurrent 
pial vessels.  The central retinal artery provides centripetal 
branches from the pial plexus and also centrifugal branches.  
 The disc and retina are exposed to intra ocular pressure   
whereas the retro laminar and proximal nerve to cerebrospinal 
fluid pressure (Hayreh and Dass 1960, Hayreh 1963 & 1974). 
 The optic nerve is surrounded by meningeal sheaths dura, 
arachnoid and pia matter upto lamina cribrosa.  There is an 
extension of the intra cranial subarachnoid space forward 
around the optic nerve to the back of the eye ball.    So any 
increase in ICP compresses the thin walled retinal veins,   as 
they cross the extension of   subarachnoid space leading to 
congestion and bulging of the disc.  Since subarachnoid space 
around optic nerve is continuous with the intracranial 
subarachnoid space, both eyes will exhibit papilloedema.  Optic 
disc does not possess the cells of Muller, which holds the nerve 
fibres together,  hence it easily swells in papilloedema. 
(c) AXOPLASMIC FLOW: 
 Normally there is a continuous flow of axoplasm along the 
optic nerve. 
1. Antegrade flow or orthograde transport: 
This is the flow from the retinal ganglion cells  
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along the optic nerve axonal fibres to their terminals in the 
lateral geniculate body1. 
• Slow component:  proteins and enzymes 
The slow component materials move at a speed of     
1-3  mm per day.  It is driven through   peristaltic waves that 
passively drive across the content and it is the component that is 
interfered early in the onset of increased intra cranial pressure. 
• Rapid component: (Subcellular organelles, mitochondria) 
Materials move at a speed of 400 – 1000mm/day.   
The velocity of the axoplasmic flow in the fast component 
depends upon the intra axonal pressure which is determined by 
the difference between the IOP gradient in the pre-laminar area 
and optic nerve tissue pressure  gradient in the post laminar 
area.  The optic nerve tissue pressure in turn is determined by 
CSF pressure in the dural sheath3. 
2. Retro grade flow:  
 Lysosomes and mitochondria flow from the lateral 
geniculate body to the retinal cells also occurs at an intermediate 
rate. 
  Mucopolysaccharides, proteins, glycolipids, gangliosides, 
phospholipids, cholesterols, smooth endoplasmic reticulum and 
associated   elements  constitute  axoplasmic material. Hayreh 
injected labelled aminoacid like leucine or protein into the 
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vitreous cavity of monkey and demonstrated accumulation in 
both fast and slow components in the lamina cribrosa   with 
increase in ICP.  The accumulation of axoplasm results in 
swelling of axons as seen by electron microscopy.   
 Radius and Anderson (1980) demonstrated  impaired slow 
axonal  transport and axonal swelling by  injecting the drug β-β’ 
imino di propionitrite (IDPN) that selectively and directly blocks 
axonal transport producing optic disc swelling in dogs,  guinea 
pigs and in monkeys. 
1. Papilloedema occurs only when there is patency of 
meningeal space surrounding the optic nerve and intra 
cranial structures.  Blockage of this space by adhesion, or 
tumours prevents papilloedema from occurring on the side 
of obstruction. 
2. Papilloedema does not occur in eyes in which antecedent 
optic  atrophy had destroyed most or all of the nerve fibres. 
3. Most importantly slow axonal transport is clearly abnormal 
in patient with papilloedema  as well as in patient with disc 
swelling from all other causes (Ischemia, inflammation,  
hypotony etc). 
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PATHOGENESIS 
 
a) Intra ocular pressure and optic nerve tissue pressure: 
i) Intra axonal pressure - which is determined by the difference 
between the intra ocular pressure gradient in the prelaminar 
area and optic nerve tissue pressure gradient in the post laminar 
area. 
ii) The optic nerve tissue pressure: 
 Which  in turn is determined by the CSF pressure in the 
dural sheaths. 
Intra axonal pressure = IOP in prelaminar area - optic nerve    
tissue pressure in post laminar           
region. 
 Normally the IOP (14-20mm Hg) is higher than the tissue 
pressure in the optic nerve (6 – 8mm Hg).  This pressure 
differential is the force driving the axoplasm in the region of the 
lamina cribrosa.  Hence a fall in the IOP or an increase in the 
optic nerve tissue pressure following a rise in the CSF pressure 
will interfere with the axoplasmic flow,   leading to stasis and 
accummulation of the   axoplasm. 
 Experimentally this was proved in a successful animal 
model   developed by Hayreh.  He produced papilloedema in 
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monkeys by slowly inflating a balloon that had been placed in 
the sub arachnoid space within the skull, thus simulating a 
space occupying  lesion. Later he demonstrated the regression of 
the papilloedema on the same animal model by opening the dura 
and arachnoid around the optic nerve on one side.  This forms 
the basis of the surgery for relieving the papilloedema viz,   optic 
nerve sheath fenestration. 
 In another study Hayreh injected fluorescein solution in to 
the CSF of the monkey and observed fluorescence of the optic 
disc. 
 This accumulation of axoplasm results in the swelling of 
axons seen by electron microscopy.  Accumulation is mainly due 
to blockage of slow axonal transport. 
 The cranial cavity is an almost rigid bony enclosure 
completely filled by tissue, CSF and circulating blood.   Within 
this enclosure CSF is constantly   produced  at the rate of 
0.37ml per minute primarily inside the ventricular system. 
b) CIRCULATION OF CSF 
 CSF is secreted by choroid plexus of lateral, third and 
fourth ventricles and ependymal lining of the ventricular system.  
CSF flows from the lateral ventricles through the inter  
ventricular foramen into the third ventricle and then to the 
fourth ventricle through the cerebral aqueduct of Sylvian and 
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out into the sub arachnoid space through the foramina of 
Luschka and Magendie.  In the subarachnoid space, CSF flows 
rostrally from the posterior fossa through the lower ventral basal 
cisterns and tentorial notch to reach the inter peduncular and 
chiasmatic cisterns.   The CSF then flows dorsally through the 
communicating cisterns to reach the dorsal cisterns, and lateral 
and superiorly from the chiasmatic cisterns into the cistern of 
the Sylvian fissure.  From the cisterns and Sylvian fissures,  CSF 
moves outward and superiorly over the cerebral convexities 
where it is  absorbed. 
 The chief route of absorption of CSF is through the 
arachnoid granulations that protrude into the venous sinuses 
and the diploic veins.    These vessels drain into the internal 
jugular vein and extra cranial veins.   
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CHART – 1 
 
Choroid plexus 
↓ 
Lateral ventricles 
↓ 
Inter ventricular foramen 
↓ 
3rd ventricle 
↓ 
Cerebral aqueduct of Sylvius 
↓ 
4th ventricle 
↓ 
Foramen of Luschka & Magendie 
↓ 
Subarachnoid space 
↓ 
Arachnoid granulations of 
Venous sinus /diploic vein 
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Under appropriate circumstances,  as little as 80cc of rapidly 
added volume (CSF, blood, oedema, tissue) will raise ICP to a 
level incompatible with life. 
CLINICAL FEATURES OF PAPILLOEDEMA 
SYMPTOMS AND SIGNS 
 
Table 1 
Non visual manifestations Visual manifestations 
1. Head ache – Early  
    symptoms.  Due to   
    stretching of meninges   
2. Nausea and projectile   
    vomiting – due to  increase   
    in  ICP. 
3. Bradycardia and   
    respiratory  failure due to  
    herniation of  medulla in  
    foramen magnum. 
4. Loss of consciousness due  
    to  compression of   
    cerebral cortex and   
    decrease in blood flow. 
5. Generalised motor rigidity  
    –  due to  crowding of   
    temporal  lobe, as a result  
    of herniation of the  
    hippocampal  gyrus  
    causes pressure on the  
    crus cerebri. 
6. Dilated pupil not  
    responding to light – due  
    to direct  pressure on the   
    oculomotor  nerve or  
    dorsal  midbrain. 
1. Transient visual  
    obscuration. 
 
2. Loss of central vision 
 
 
3. Diplopia 
 
 
 
4. Visual field defects 
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 VISUAL MANIFESTATION: 
1. Transient visual obscuration: 
 Transient obscuration of vision may occur in both eyes 
simultaneously with rapid recovery usually lasting seconds but 
sometimes lasting hours. 
 Patients may experience upto 20-30 attacks per day,  with 
obscurations precipitated by change of posture, particularly from 
sitting to the standing position or from the lying down to sitting 
or standing position. 
i. The cause of these transient obscuration is related to 
transient compression or ischaemia of the intra cranial portion 
of the optic nerve or optic chiasm by a distended third ventricle. 
ii. Ischaemia of optic nerve head and downward herniation 
of the hippocampal gyrus in the tentorial notch. 
2. Visual field defects: 
(i). Concentric enlargement of the blind spot is the most 
common and   frequently the only visual field defect observed is 
patient with papilloedema. 
  The cause of the enlarged blind spot is compression,  
detachment and lateral displacement of the peripapillary  retina.  
The enlarged blind spot represents a refractive scotoma caused 
by hyperopia of the peripapillary retina. 
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  Other visual field defects are  
(ii)  concentric constriction   
(iii) homonymous hemianopia  
iv)  central and arcuate scotoma              
v) complete blindness.  Inferior nasal quadrant was most 
frequently affected than temporal quadrant.  Thus an eye may be 
left with only a temporal island of vision before progressing on to 
complete blindness. (vi) constriction of the visual field is late sign 
which occurs in chronic papilloedema as it progresses to optic 
atrophy. 
3)  Loss of central vision 
Acute or progressive loss of central vision may be due to    
i) Haemorrhage  or exudates  at the macula.  
ii) Increased optic nerve tissue pressure causing    
    occlusion of  prelaminar anterioles. 
iii) The underlying etiological condition  causing retinal   
     vascular occlusion. 
4) Diplopia 
 This may result from compression  or stretching of the 
abducent nerve at the base of the skull which may be unilateral 
or bilateral (false localizing sign). 
 Very occasionally trochlear nerve palsy may also occur,  
presumably from compression of the dorsal midbrain or direct 
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compression of the nerves themselves by a ballooned supra 
pineal recess. 
OPHTHALMOSCOPIC APPEARANCE: 
 As suggested by Hughlings and Jackson (1871) and by 
Bolloyt and Beecton (1966) papilloedema may be classified into 
four types (a) early (b) fully developed (c) chronic (d) atrophic. 
a) Early papilloedema: 
 The early phase of papilloedema consists of the incipient 
disc changes that occur before the development of obvious disc 
swelling.  The features include, hyperemia of the optic disc 
blurring of the peripapillary retinal  nerve fibre layer,  swelling of 
the optic disc, blurring of the disc margins, peripapillary flame 
shaped haemorrhages and absent spontaneous venous 
pulsations. 
b) Fully developed papilloedema: 
 The characteristics are, increase in disc swelling (2-6 
diopters), venous engorgement. Numerous splinter 
haemorrhages,  microaneurysms,  partial obscuration of 
traversing blood vessels, obliteration of physiological  cup, 
vessels obscured by nerve fibre layer edema,  peripapillary flame 
shaped  haemorrhages, cotton wool spot which are due to focal 
retinal infarcts,  tortuous vessels surrounding the disc. 
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Severe cases may show circumferential retinal folds,  
Patons lines (peripapillary chorio–retinal folds), hard exudates 
and haemorrhage in macula giving macular fan  appearance. 
c) Chronic papilloedema: 
 This is characterized by: 
 Resolved haemorrhages, exudates and edema over the disc 
along with loss of the central cup.  The disc develops a rounded 
appearance.  There is appearance of pallor of the disc.  Optic 
discs are markedly elevated with a champagne cork appearance.  
Opto-ciliary shunts and drusen may occur.  Most patients with 
chronic papilloedema have evidence of nerve fibre layer atrophy.  
The atrophy ranges from slit like defects to diffuse loss which is 
readily appreciated by  red free filter of direct ophthalmoscopy or 
slit lamp bio microscopy. 
d) Post papilloedemic optic atrophy (secondary optic atrophy) 
 Characteristics are: 
 Grey white pallor of disc with blurred margins. 
 Attenuated sheathed vessels. 
 Gliosis on the disc surface and margin. 
 Frisen grading system is most useful as it classifies the 
papilloedema grade by severity. 
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FRISEN GRADING SYSTEM 
Table - 2 
Stage 0:Normal optic disc 
     Blurring of nasal, superior, and inferior poles in inverse   
             proportion to disc diameter. 
             Radial  nerve fibre layer (NFL) without NFL tortuosity. 
             Rare obscuration of a major blood vessel,  usually on   
             the upper pole. 
Stage 1:Very early papilloedema  
      Obscuration of the nasal border of disc. 
     No elevation of the disc borders. 
    Disruption of normal radial NFL arrangement with    
    greyish opacity along   NFL bundles 
     Normal temporal disc margin. 
     Subtle greyish  halo with temporal gap (best seen with   
             IDO) 
     Concentric or radial retro choroidal folds. 
Stage 2:Early papilloedema 
     Obscuration of all borders 
    Elevation of the nasal border 
    Complete peripapillary Halo   
Stage 3:Moderate papilloedema 
     Obscuration of all borders 
     Increased diameter of optic nerve head 
    Obscuration of one or more segments of major blood   
    vessels leaving the disc peripapillary halo irregular outer  
    fringe with finger  like extensions 
Stage 4:Marked papilloedema 
     Elevation of the entire nerve head 
     Obscuration of all borders 
     Peripapillary halo 
    Total obscuration on the disc of a segment of a major  
    blood vessel. 
Stage 5:Severe papilloedema 
    Dome shaped protrusion representing anterior   
    expansion  of the optic nerve head. Peripapillary halo is   
    narrow and smoothly  demarcated. 
    Total obscuration of a segment of a major blood vessel   
             may or may not be  present.    Obliteration of the optic    
             cup. 
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ETIOLOGY 
 
Mechanism of increased ICP 
1. An increase in the intra cranial tissue by a space 
occupying lesion. 
2. An increase in intra cranial tissue volume by focal or 
diffuse cerebral edema. 
3. A decrease in total volume within the cranial vault by 
thickening of the skull. 
4. Blockage of the flow of CSF within the ventricular system 
or within the arachnoid granulations. 
5. Reduced absorption of CSF from obstruction or 
compromise of venous flow both intra cranially and extra 
cranially. 
6. Increased production of CSF by an intra cranial tumour at 
a rate that precludes absorption for maintenance of normal 
ICP. 
• Intra cranial masses 
• Aqueductal stenosis 
• Brain abscess 
• AV malformation 
• Trauma 
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• Acute and chronic subdural haematoma 
• Epidural hematoma 
• Subarachnoid haemorrhage 
• Septic and aseptic meningitis and encephalitis 
• Carcinomatous / lymphomatous / leukemic 
meningitis 
• Cerebral and leptomeningeal gliomatosis 
• Spinal cord lesions 
• Landry Guillain – Barre syndrome 
• Chronic inflammatory demyelinating polyneuropathy 
(CIDP) 
• Mucopolysaccharoidosis 
• Cranio synostoses 
• POEMS syndrome 
• Multiple myeloma 
• Hyperthyroidism 
• Late onset citrullinemia 
• Pseudo Tumor Cerebri 
1.  Intra cranial masses 
 Intra cranial masses produce raised ICT by several 
mechanisms 
i) They may act solely as space occupying lesions 
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ii) They may produce focal or diffuse cerebral edema 
iii) They may block the CSF drainage pathways by direct 
compression or infiltration of the arachnoid villi or 
cerebral venous sinuses. 
iv) Producing increased protein and blood products that 
secondarily block  the arachnoid villi. 
Papilloedema does not develop in every patient with a 
cerebral tumor. 
Infra tentorial tumours are more likely to produce 
papilloedema than supra tentorial tumours. 
 An intracranial tumour in any position may induce 
papilloedema , the highest percentage being found with tumours 
of the midbrain, parieto occipital region and cerebellum. 
Papilloedema due to tumours of the anterior fossa is relatively 
rare and occurs late in the course of the disease.  In general,  
those tumours which tend to produce internal hydrocephalus 
are most likely to cause papilloedema.  The site of the tumour is 
more important than its nature,  size or rate of growth. 
 Papilloedema may occur with any type of intracranial mass   
including primary and secondary metastatic brain tumours.  
Hamartomas, teratomas, giant aneurysms, A.V. malformations,   
cysticercus cysts, and granulomas (eg: in syphilis, sarcoidosis or 
tuberculosis).  
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 According to  Stopford (1928) supra tentorial tumour rarely 
cause primary obstruction to the flow of CSF through the 
aqueduct of Sylvius,  instead such tumors produce papilloedema 
by deflection of the falx and pressure upon the great vein of 
Galen. 
 Tumors below the tentorium produce papilloedema by 
obstruction of aqueduct.  Some infra tentorial masses do not 
obstruct the aqueduct, but still produce papilloedema.  Stopford 
(1928) suggested that elevation of tentorium with pressure on 
the vein of Galen is responsible. 
2. Obstruction to flow of CSF: 
Aqueductal stenosis: This often presents in childhood.   
It may be congenital which may or may not be associated with 
Chiari malformation or acquired from intracranial infections 
such as toxoplasmosis or mumps ependymitis.  Sometimes it 
can present in infants with microcephaly,  in adult with head 
ache,  dorsal mid brain syndrome, meningitis, or endocrine 
disturbances from the compression of the pituitary gland, 
seizures, gait disturbances and CSF rhinorrhea.  Neuro imaging 
shows marked enlargement of lateral and third ventricles with 
normal fourth ventricle.  The symptoms  are relieved by 
ventriculo peritoneal shunt. 
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3. Trauma: 
i) Papilloedema occurs in 20 – 30% of persons who have  
suffered severe head trauma.  The increased ICP is caused by a 
severe subarachnoid haemorrhage or a significant intra cerebral 
subdural or epidural haematoma.  It may also be caused in some 
cases by cerebral venous sinus thrombosis or diffuse or localized 
cerebral oedema.   Papilloedema may occur immediately or 
several days after injury or up to 2 weeks later. 
ii) Subarachnoid haemorrhage: 
 This usually produces papilloedema  by blocking CSF  
flow within the ventricular system or blocking CSF absorption at 
the arachnoid granulations. 
iii) Papilloedema from acute and chronic subdural  
hematoma.  Papilloedema occurs in patient with both acute and 
chronic subdural hematoma.  Gardner proved that papilloedema 
occurs early in children but late in adult,  similarly most often 
occur in acute subdural hematoma than chronic subdural 
hematoma. 
iv) Epidural hematoma: 
Stevenson et al (1964) reported the case of a patient  
who developed papilloedema from an epidural hematoma that 
occurred several weeks after a vertex skull fracture.  
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Papilloedema resulted from compression of the superior sagittal 
sinus in this case. 
4. Septic and aseptic meningitis and encephalitis: 
 Meningitis produces papilloedema by (a) diffuse cerebral 
edema, (b) obstruction to CSF flow by aqueductal stenosis or    
(c) obstruction of CSF resorption through arachnoid 
granulations.  Papilloedema occurs in 2.5% of patients with 
meningitis, more so in tubercular meningitis (25% of cases). 
 Approximately 19% of patients with viral encephalitis have 
papilloedema.  Herpes simplex,  Herpes zoster, and measles 
encephalitis are commonly associated with papilloedema 
whereas rubella, mumps and varicella are not associated with 
papilloedema.  Patient with poliomyelitis may develop increased 
intracranial pressure during both acute and convalescent phases 
of the disease. 
Infection: 
 In almost all CNS infection and inflammation, swelling of 
the optic disc may occur without elevated ICP, presumably from 
inflammation of the optic nerve. 
5. Elevated venous pressure: 
 Obstruction of cerebral venous drainage may result in 
increased ICP and papilloedema.  The obstruction is most often 
caused by compression or thrombosis with the vessels more 
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commonly being affected are the superior  sagittal and 
transverse (lateral) sinuses.  The common causes are: 
 Tumours – those obstructing the superior sagittal sinus are 
usually extra axial like meningiomas.  The transverse sinuses 
can be occluded by acoustic neuromas,  meningiomas and 
metastatic tumours1. 
 Septic thrombosis of the transverse sinus occurs in the 
setting of acute or chronic otitis media in which there is 
extension of the infection to the mastoid  air cells and then to the 
adjacent transverse sinus. 
 Septic thrombosis of the cavernous sinus also can produce 
papilloedema but late in the course of the process. 
6. Extra cranial lesions: 
 i) Tumours of the spinal cord may produce increased ICP 
by two  mechanisms.     
a) Some tumours may be located in the high cervical region and 
the upward swelling of the tumour with compression of the 
cerebellum and obstruction of the CSF flow through the foramen 
magnum. 
b) The majority of the tumours of the spinal cord associated with 
papilloedema are however ependymomas and neurofibromas 
located in the thoracic and lumbar regions.  These tumours 
produce extremely high concentrations of protein in the CSF and 
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the papilloedema is probably a result of obstruction of the 
drainage of CSF at the arachnoid granulations by the proteins. 
ii) Landry Guillain - Barre syndrome (GBS) 
  Proteins in the arachnoid villi and granulations alter 
the cerebral  venous dynamics or cause partial venous 
thrombosis leading to increased ICP. 
iii)Chronic inflammatory demyelinating polyneuropathy 
(CIDP) causes increased ICP by increasing in the protein 
concentration which is the hallmark of the disease. 
iv) The POEMS syndrome is an unusual multi system  
disorder characterized by polyneuropathy (P),  organomegaly (O) 
endocrinopathy (E), monoclonal gammopathy (M) and skin 
changes (S). Patients with POEMS syndrome occasionally 
develop increased intra cranial pressure  associated with 
papilloedema. 
7. Post convulsive papilloedema 
 Low grade or transient papilloedema has been observed 
after a long series of convulsions (status epilepticus). 
8. Edema of optic disc with systemic diseases 
 i) Cardiopulmonary insufficiency, chronic respiratory 
acidosis,  hypercapnia,  and polycythemia cause an increase in 
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the venous pressure which leads to increased intracranial 
pressure and thereby papilloedema. 
 ii) Pulmonary emphysema leads to respiratory  acidosis 
which causes an accumulation of CO2 in brain tissue reflected 
by inversion of the normal CO2 tension ratio between 
cerebrospinal fluid and arterial blood.  This in turn causes 
dilatation of cerebral capillaries and increases intra cranial blood 
volume. 
 iii) Extensive obesity as in Pickwickian syndrome causes ↓ 
vital capacity, polycythemia, cyanosis along with bilateral disc 
edema. 
 iv) Hypoparathyroidism and papilloedema 
  Both idiopathic and acquired forms of 
hypoparathyroidism are associated with papilloedema of mild 
degree. 
 v) Thrombocytopenic purpura and edema of optic disc. 
 vi) Leukemia and   papilloedema 
9. Arterio Venous Malformation:  
 AVMs need not rupture to produce papilloedema.  The 
mechanism producing increased ICP is by direct shunting of  
arterial blood from AVMs, into cerebral venous system leading to  
increased cerebral venous pressure and decreasing CSF 
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absorption.  Both intra cerebral and dural based AVMs involving 
the transverse sinus are associated with papilloedema. 
10. Others: 
Non infective inflammatory  
i) Sarcoidosis - Papilloedema may be caused by aseptic 
meningitis or dural venous sinus thrombosis. 
ii) Behcet’s - Pseudo tumour cerebri with papilloedema is the 
most common presentation of dural venous sinus thrombosis in 
Behcet. 
11. Inborn errors of metabolism 
• Mucopolysaccharoidosis – obstruction  of CSF over cerebral 
convexities, or in the arachnoid villi or both by deposits of 
mucopolysaccharide in the meninges, leading to delayed 
CSF absorption. 
• Citrullinemia –  is caused by deficient activity of argino 
succinate synthetase, a urea –cycle enzyme.   This disorder 
may present acutely in neonates, sub acutely in children or 
as a late onset condition in young adults.  When the 
condition is of the late – onset type,  it may produce 
increased intra cranial pressure associated with 
papilloedema.    
• Craniosynostosis  
• Plasma cell dyscrasia  
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• Toxins – (eg) lead can damage Blood brain barrier, cause 
severe cerebral edema and ↑ICP   
• Hyperthyroidism – due to compression or ischaemia of 
optic nerve caused by dysthyroid orbitopathy 
• Pseudo Tumor Cerebri 
12. Pseudo Tumour Cerebri (Benign Intra cranial 
hypertension / Idiopathic intra cranial Hypertension) 
 This syndrome was first recognized by Quincke (1897).  
Warrington (1914) was the first to use the term "Pseudo tumour 
cerebri".  Foley introduced the term "Benign intra cranial 
hypertension". 
Clinical manifestation: 
 The most common presenting symptom in patients with 
pseudo tumour cerebri is head ache, occurring in more than 
90% of cases.  Headache is usually generalized, worse in the 
morning and aggravated when cerebral venous pressure is 
increased by some type of Valsalva manoeuvre  (coughing, 
sneezing etc) 
- nausea, vomiting,  dizziness, and pulsatile tinnitus 
- visual manifestations like   
(a) transient visual obscuration     
(b) loss of vision from macular haemorrhages,   exudates,  
     pigment epithelial changes,  retinal   striate, choroidal  
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     folds,  sub retinal  neovascularization or optic atrophy  
    (c) horizontal diplopia from unilateral or bilateral  
 abducent nerve palsy and rarely  
    (d) Vertical or oblique diplopia from trochlear nerve    
 paresis, oculomotor nerve paresis or skew deviation. 
Aetiology of Pseudo Tumor Cerebri 
 Usually idiopathic in over 90% of cases.  Pseudo tumour 
cerebri  occurs in young obese women and occasionally men 
with no evidence of underlying disease. 
 In about 10% patients, particularly in men and non obese 
young women,  Idiopathic Intra cranial Hypertension develops in 
a number of clinical settings namely.  
Obstruction and impairment of cerebral venous drainage. 
Endocrine and metabolic dysfunction viz, Addisons disease, 
hypoparathyroidism, hyperthyroidism, hypothyroidism, 
menarche, menopause,  obesity (idiopathic) pregnancy, exposure 
to drugs like corticosteroids, oral contraceptives, tetracycline,  
nalidixic acid,   amiadrone,  VitA, systemic illness like anaemia, 
chronic respiratory insufficiency / hypertension, multiple 
sclerosis,  Systemic Lupus Erythematous, and withdrawal of 
certain drugs  (eg) steroids. 
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PATHOLOGY 
 
 The pathology of papilloedema shows  signs of passive 
edema without evidence of inflammation.  The oedematous 
changes are located in the optic nerve head in front of lamina 
cribrosa.  The small blood vessels are engorged and tortuous.  
The nerve fibres in the optic nerve head are swollen and 
axoplasmic stasis is noted in them.  The physiological cup gets 
filled in and the internal limiting membrane is raised.  The nerve 
fibres become swollen and varicose and ultimately degenerate.  
They shows numerous  cytoid bodies in front of lamina cribrosa.  
Electron microscopy shows engorgement of axons in the laminar 
portion of the optic nerve.  The swollen axons are filled with 
mitochondria.  The neuroglia proliferates and the mesoblastic 
tissue around the vessels becomes thickened.  Retinal exudates 
distributed radially along the folds may be present in the 
macular region corresponding to the clinical appearance of a 
macular fan or macular star.   The separation of the swollen 
optic disc from adjacent retina is in the form of an 'S' shaped 
curve.  Compression, detachment and lateral displacement of the 
peripapillary retina appears to be reason for enlarged blind 
spot4. 
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DIAGNOSIS 
 The most important method of diagnosing  papilloedema is 
careful ophthalmoscopic examination.1) red free ophthalmoscopy 
and 2) slit lamp bio-microscopy with a hand held lens or contact 
lens. If the diagnosis remains uncertain several options are  
available. 3) Fluorescein angiography is often used to confirm 
early papilloedema.  5ml of 10% fluorescein  sodium  is  rapidly 
injected into a superficial arm vein.  The passage through retinal 
vessels is then observed and photographed at rapid intervals 
with a cobalt blue filter interposed in front of the light source to 
visualize the fluorescence of the dye.  The early phase shows 
capillary dilatation dye leakage and micro aneurysm formation.  
Later films show leakage of dye beyond the disc margins.           
4) Orbital echography is useful in cases of questionable 
papilloedema.  This sensitive test determines of the diameter of 
the optic nerve. 5) By performing A and B scan ultrasonography   
we can determine optic disc edema and optic disc drusen.         
6) CT scan and MRI can be used to detect evidence of an intra 
cranial mass or hydrocephalus.  
High resolution MRI of the orbit shows characteristic 
changes of the optic nerves and posterior globe in papilloedema.  
The Subarachnoid space becomes distended, the nerve sheath 
widens and there is flattening of the posterior sclera.   The 
prelaminar  optic nerve may enhance and protrude anteriorly. 
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COURSE 
 
 The rapidly developing papilloedema depends to a large 
extent on the etiology and degree of the increased ICP. 
 Clinically detectable papilloedema is not usually present 
with acute elevation of ICP, and may take over a week to develop. 
Cases  have been reported of papilloedema within 2 - 4hours 
after intra cranial haemorrhage. 
 Fulminant haemorrhagic papilloedema was also seen 
within  5 – 8 hours in conditions like metastatic frontal lobe 
tumour and epidural haematoma. 
 In addition, minimal papilloedema may exist and suddenly 
become fully developed in several hours in certain settings such 
as encephalitis with development of  cerebral  abscess. 
 Fully developed papilloedema may resolve completely 
within hours,  days or weeks depending on the way in which ICP 
is lowered.   
In humans,  papilloedema can resolve 6 – 8 weeks after a 
successful craniotomy to remove a brain tumour.   Optic disc 
edema may improve in less than a week following optic nerve 
sheath decompression. 
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 In most cases the retinal venous as well as disc capillary 
dilatations begin to regress as soon as ICP is lowered to a normal 
level.  During the next few days to weeks disc hyperemia and 
elevation resolve.  The last abnormalities to disappear  are  
blurring of the disc margins and abnormalities of the 
peripapillary retinal nerve fibre layer. 
 In severe cases papilloedema resolves into optic atrophy.  
Optic atrophy following papilloedema is referred to as 
'Secondary'  optic atrophy. 
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DIFFERENTIAL DIAGNOSIS 
 
Pseudo papilloedema: 
 This reflects differing morphological  appearance of the 
disc. 
1. Anamolously elevated optic disc. 
 i) Small hypermetropic disc, tilted optic disc,  hypoplastic 
optic disc 
 ii) Myopic disc that are asymmetrical 
 iii) Optic nerve head drusen especially burried drusen 
which may be mistaken for early papilloedema.  However unlike 
true papilloedema, there is no obscuration of superficial fine  
vessels  at the edge of the disc.  Auto fluorescence may be 
positive which helps in the diagnosis. 
2. Medullated nerve fibres around the disc. 
3. Bergmiester’s papilla 
4. Bilateral disc swelling may be caused by any one of the 
following 
 - malignant hypertension 
 - bilateral papillitis 
 - bilateral compressive  thyroid ophthalmopathy 
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 - bilateral simultaneous anterior ischaemic optic  
  neuropathy 
- bilaterally compromised venous drainage in CRVO or   
  carotico cavernous fistula. 
5. Optic perineuritis  
6. Infiltrative optic neuropathy  eg: from leukemia 
7. Compressive optic neuropathy eg: from optic nerve sheath 
meningioma. 
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TREATMENT 
 
  The main stay of treatment is to reduce the increased Intra 
cranial Pressure. If timely decompression is successfully 
performed,  the effect is remarkable.  Along with relief of the 
general symptoms like head ache, vomiting, stupor etc, vision 
improves rapidly (unless the nerves have been irreversibly 
damaged) and papilloedema subsides. 
ICP may be reduced by medical / surgical management 
(i) If increased ICP is directly related to a mass lesion – 
Removal of the lesion is the treatment of choice. 
(ii) If the lesion cannot be removed or if CSF absorption is 
reduced at the level of arachnoid villi – Shunting of CSF 
into atrial or peritoneal cavities 
(iii) If there is cerebral edema, osmotic agents diuretics or 
corticosteroids may reduce swelling particularly in acute 
period. 
(iv) If papilloedema is due to pseudo tumour cerebri, it is 
medically managed  
(v) Surgical treatment       
Treatment of Pseudo Tumor Cerebri includes: 
1. Withdrawal of causative drugs. 
2. Weight reduction. 
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 3. Medical therapy 
T. Acetazolamide 1gm/day – divided doses 250mg  
Qid or 500 mg B.D 
This reduces production of CSF by inhibition of 
carbonic anhydrase 
   ↓ 
  ↓ Na ion transport across the choroidal epithelia. 
   ↓ 
  ↓ CSF production 
 
Side effect: 
  Parasthesia,  numbness, lethargy 
  decreased  libido, metallic / dry taste in mouth. 
 4. Repeated lumbar punctures - are advocated as non 
medical, non surgical method of relieving the increased ICP of 
Idiopathic Intra Cranial Hypertension.  The theory behind is that 
the needle used for lumbar puncture creates an opening in the 
dura through which CSF leaks.  With several lumbar puncture,  
one creates a sieve that allows sufficient egress of CSF that ICP 
is normalized.  This procedure is painful, technically difficult to 
perform and causes a low pressure headache. 
 Surgery is considered under the following circumstances. 
1. Progressive loss of vision despite maximal medical therapy. 
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2. Severe or rapid vision loss at onset, including the 
development of an afferent pupillary defect or signs of 
advanced optic nerve dysfunction. 
3. Severe papilloedema causing macular edema or exudates.  
Surgical procedure includes (a) optic nerve sheath 
decompression (ONSD) and (b) CSF diversion procedures. 
Hayreh (1969)  initiated optic nerve sheath decompression 
through lateral orbitotomy. 
a) Optic nerve sheath decompression: ONSD 
  In this procedure,  a window or multiple slits are made in 
the dural sheath of the optic nerve immediately behind the globe.  
A successful ONSD results in resolution of papilloedema on that 
side and occasionally on the other side with improvement in the 
visual function in many cases.  The procedure immediately 
reduces pressure on the nerve by creating a filtration apparatus 
that controls the intra vaginal pressure surrounding the orbital 
segment of the optic nerve. 
Complication of ONSD are: 
1. Extra ocular motility dysfunction – usually transient.   
    Usually  involves the lateral rectus muscle. 
2. Pupillary dysfunction 
3. Loss of vision from vascular occlusion 
 a) CRAO – Central Retinal Artery Occlusion 
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 b) BRAO – Branch Retinal Artery Occlusion 
 c) Choroidal ischaemia / infarcts - 
4. New visual field defect 
5. Orbital haemorrhage 
6. Transient or protracted blindness 
7. Globe perforation 
                  
b) CSF diversion procedures                                                                           
  A CSF diversion procedure treats Idiopathic intra cranial 
Hypertension by lowering the intra cranial pressure. 
 Lumbo peritoneal shunt  is more commonly performed 
than ventriculo peritoneal  shunting. 
 LP shunt in which a silicone tube is placed percutaneously 
between the lumbar sub arachnoid space and the peritoneal 
cavity. 
Complication of shunting includes: 
1. Shunt valve or tubing obstruction 
2. Over shunting (low pressure head ache) 
3. Catheter migration / abdominal pain 
4. Infection 
5. CSF leak 
6. Cerebellar tonsillar herniation (acquired Chiari 
malformation)  
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MATERIALS AND METHODS 
 
 The study of  etiologies and ophthalmoscopic findings,  CT 
findings of papilloedema in South Tamil Nadu was carried out in 
the Department of Ophthalmology, Tirunelveli Medical College 
Hospital, Tirunelveli. 
Settings: Ophthalmology ward, Neuro Medicine 
ward, Neuro surgical ward, Medical ward, 
Pediatric ward. 
Study design: Single centre observational prospective 
hospital based study. 
Period of study:  June 2007 to June 2009. 
Ethical approval: Obtained 
Tirunelveli Medical College Hospital is a tertiary care centre  
in South Tamil Nadu.  The patient population is fairly 
representative sample of the disease pattern in this region. 
 75 patients with papilloedema in the above period who 
satisfied the set criteria were included. 
 1). Papilloedema is defined as bilateral passive non-
inflammatory  edema of the optic disc due to raised intra cranial 
pressure which is almost always bilateral and without any visual 
deficit. 
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 2). The patients presented with headache, nausea,  
vomiting, defective vision with ophthalmoscopic findings of 
fundus with papilloedema. 
 3). 75 patients, with visual acuity recording,  field charting, 
colour vision, neurological examination, CT brain were included. 
Exclusion criteria: 
 1). Inflammatory optic  disc edema.   
 2). Unilateral papilloedema were excluded. 
 3). Pseudo papilloedema were excluded. 
 After obtaining consent from either patient or relatives,  all 
patient in the study group were evaluated by complete medical 
history, full ophthalmoscopic examination,  fundus examination 
and CT scan and MR imaging of brain in indicated cases. 
Clinical history: 
 Clinical history was recorded from either the patient or 
his/her relatives.  Special emphasis was given to the presenting 
complaint,  mode of onset,  duration,  associated features,  
activity of the patient at the time of onset and the pattern of 
presentation. 
 Presence or absence of risk factors for papilloedema were 
also noted.  Past H/o HT,  steroid intake, oral contraceptive pills, 
trauma, tumor, treatment were carefully sought. 
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Ophthalmic evaluation:   
Visual acuity, tension, colour vision, field, fundus 
examination with direct ophthalmoscope, indirect 
ophthalmoscope and +90 D lens were noted.  A detailed 
neurological examination was done in each  patient which 
included examination of higher functions, cranial nerves,  
sensory system, motor reflex and cerebellum. 
 Investigations like blood Hb%, TC, DC, blood sugar, CT 
brain, MRI brain were done in all patients. 
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OBSERVATION 
1. AGE: 
 The 75 patients studied were classified according to age 
and the percentage of papilloedema in each age group was 
studied 
Table 3  
Age group No of cases Percentage 
Less than 20 years 12 16% 
21 – 30 years 30 40% 
31 – 40 years 11    14.7 % 
41 – 50 years 13   17.3% 
51 – 60 years 9 12% 
 
 
Age group
Chart 2
14.7%
17.3%
12% 16%
40%
< 20 year
21 - 30 year
31 - 40 year
41 - 50 year
51 - 60 year
 
  
 
46
 
2. SEX: 
 Out of the 75 patients studied 43 of them were females 
(57.3%) and 32  of them were males (42.8%) 
  
 
Sex
Chart 3
57%
43% Male
Female
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3. DURATION OF ILLNESS: 
Table 4 
  
Duration of illness No of cases Percentage 
Acute ( < 1month) 
Sub acute(1-3month) 
Chronic (3 month-1year) 
Very chronic (> 1 year) 
52 
16 
5 
2 
69% 
21% 
7% 
3% 
 
 
Duration of illness
Chart 4
69%
21%
7% 3
0
10
20
30
40
50
60
70
<1 mth 1-3mth 3mth-
1yr
>1yr
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4. PRESENTING SYMPTOMS: 
Table 5 
Symptoms No of cases Percentage 
Head ache 
Nausea, Vomiting 
Defection vision 
Diplopia 
66 
33 
29 
11 
88% 
26% 
23% 
9% 
 
 
Presenting symptoms 
Chart 5
88%
 26%  23%
 9%
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
Headache Nausia,
vomiting
Defection
vision 
Diplopia
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5. VISUAL LOSS: 
Table 6 
  
Visual loss No of cases Percentage 
Good (>6/18) 
Moderate(6/60 – 6/18) 
Poor vision (<6/60) 
58 
6 
11 
77.4% 
8% 
14.6% 
  
 
 
Visual loss
Chart 6
14.6%
77.4%
8% Good
Moderate
Poor vision
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6. VISUAL FIELD DEFECT: 
Table 7  
Visual field defect No of cases Percentage 
Enlarged blind spot 
Peripheral field constriction 
Normal 
Not able to record 
Inferior quadrant defect 
Homonymous hemianopia 
30 
16 
19 
7 
1 
2 
40% 
21.3% 
25.3% 
9.3% 
1.3% 
2.6% 
  
 
Visual field defect
Chart 7
25.3%
9.3%
1.3%
40%
21.3%
2.6% Enlarged blind
spot
Peripheral field
constriction
Normal
Not able to
record
Inferior quadriant
defect
Homonymous
hemianopia
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7. RAPD noted in 6 cases 
 
8. LOCALISING NEUROLOGICAL SIGNS: 
 
Table 8 
Localising neurological signs Percentage 
III, IV N palsy (including Webers 
syndrome) 
 
VI N palsy 
Hemiplegia 
8% 
 
16% 
13% 
 
 
 
Localising Neurological signs
Chart 8
8%
16%
13%
0%
2%
4%
6%
8%
10%
12%
14%
16%
III, IV N
palsy
VI N palsy Hemiplegia
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9. OPHTHALMOSCOPIC EXAMINATION: 
Table 9 
Ophthalmoscopic 
examination 
No of cases Percentage 
Early papilloedema 
Established papilloedema 
Chronic papilloedema 
Atrophic papilloedema 
Unilateral optic atrophy with 
contra lateral papilloedema 
(Foster Kennedy syndrome) 
 
30 
25 
15 
3 
2 
40% 
33% 
20% 
5% 
2% 
  
 
Ophthalmoscopic examination
Chart 9
33%
40%
2%
5%
20%
Early
papilloedema
Established
papilloedema
Chronic
papilloedema
Atrophic
papilloedema
Unelevated optic
atrophy
 
  
 
53
 
10. CT FINDINGS: 
Table 10 
CT findings No of cases Percentage 
Normal 
Tumour 
Thrombosis 
AVM 
Others 
40 
25 
3 
1 
6 
53.4% 
33.3% 
4% 
1.3% 
8% 
 
CT was normal in 40 patients of which 25 had pseudo tumour 
cerebri, 9 had malignant hypertension, 3 had PIH and 2 had iron 
deficiency anaemia. 
 
CT Findings
Chart 10
33.3%
53.4%
8%
1.3%
4%
Normal
Tumor
Thrombosis
AVM
Others
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11. ETIOLOGY: 
Table 11 
Etiology No of 
cases 
Percentage 
Idiopathic intra cranial hypertension 
Malignant hypertension 
Tumour-supratentorial 
Infratentorial                                         
PIH 
AVM 
Anaemia 
TB meningitis 
ADEM 
Multiple sclerosis 
CVT 
Dural sinus thrombosis 
Sagittal sinus thrombosis 
Behcet syndrome 
25 
9 
9 
14 
3 
1 
2 
5 
1 
1 
2 
1 
1 
1 
33.3% 
12% 
12% 
18.6% 
4% 
1.3% 
2.6% 
6.6% 
1.3% 
1.3% 
2.6% 
1.3% 
1.3% 
1.3% 
 
 
Etiology
Chart 11
12%
18.6%
4%
33.3%
12%
1.3%
2.6%
6.6%
1.3%
1.3%
2.6%
IIH
Malignant HT
Tumour-Supra tentorial
Infra tentorial
PIH
AVM
Anaemia
TB meningitis
ADEM
Multiple sclerosis
CVT
Dural sinus thrombosis
Sagittal sinus thrombosis
Behcet syndrome
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DISCUSSION 
 
1. Age: 
 Out of the 75 cases 16% occurred in the first 2 decades,  
40% in the 3rd decade, 14.7% in 4th decade and 12% beyond 5th 
decade of life. 
 These results are similar to the study by Subramaniam et. 
al. who reported 52% in the 3rd decade11. 
2. Sex: 
 57.3% were females and 42.8% were males.  In the study of 
Subramaniam et al, they found 55% of males and 42% females. 
3. Duration of illness: 
 Similar to the other study mentioned above, 69% were 
acute, 21% sub acute, 7% chronic and 3% very chronic illness. 
4. Presenting symptoms: 
 Head ache was the commonest symptom in 88% of cases, 
similar to 85% in the study of Subramanian, et al11  Nausea and  
vomiting was present in 26% as compared to 56% in 
Subramaniam et al study.  This can probably be explained by 
Benign Intra Cranial Hypertension being our predominant 
etiology (40%) as compared to SOL 73% in their study. 
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5. Visual loss: 
 Fall of vision from 6/18 – 6/60 was noted in 8% and <6/60 
in 14.6% similar to those in other studies.  The 11 patients with 
poor vision had etiologies of dural venous thrombosis,  cortical  
vein thrombosis, recurrent CP angle tumour, Neuro 
cysticercosis, fronto parietal perisylvian anaplastic astrocytoma 
grade 3, supra tentorial space occupying lesion and sphenoid 
ridge meningioma. 
 Diplopia was observed in 24% of patients of which 16% 
were due to V1nerve palsy (false localizing sign) and 8% were due 
to III & IV nerve palsy1. 
6. Visual field defect: 
 Enlarged blind spot noted in 42.6% of cases, peripheral 
field constriction 21.3%, no field defect was noted in 18.6% of 
cases (13) Field could not be tested in 14.6% because of poor 
vision. 
 Hemianopia was observed in 2 cases which had associated 
signs (i) cerebellar  signs (Neuro cysticercosis – multiple cyst in 
cerebellum and cerebral cortex)   (ii)  Weakness of right upper 
and lower limb (mass in parietal lobe). 
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7. Relative afferent pupillary defect: (RAPD) 
 RAPD was noted in 4 cases, of which secondary optic 
atrophy occurred in 3 cases.  One case with BIH came to OPD 
with V/A, RE 6/60, LE –CFCF, RAPD was present in the left eye, 
LP was done – no cells in CSF (4ml drained to decrease ICT) she 
was treated with Inj.Solumedrol and lasix for 3 days.  After 1 
week papilloedema resolved, her vision  improved to 6/18 and 
after 1 week to 6/6 both eyes. 
 Absolute afferent pupillary defect in both eyes was noted in 
2 cases of Dural venous thrombosis. 
8. Neurological signs of localizing value were detected in 37% of 
cases as compared to 70% in Subramaniam et al study. 
 IV N palsy was noted in 16% cases and other cranial nerve 
palsy were noted in 8% Hemiplegia in 13% (14) 
 14.6% of patients who presented at OPD directly were 
detected as papilloedema and referred to neurosurgery 
department for diagnosis of SOL 2 cases were diagnosed as 
having granuloma parietal lobe, and 1 having tempero parietal 
SOL, 7 cases were diagnosed as BIH. 
9. Ophthalmoscopic examination: 
 40% of the 75 patients showed early papilloedema, 34.7% 
showed established papilloedema, 20% showed chronic 
papilloedema, 5.3% atrophic papilloedema. 2 cases of Foster 
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Kennedy syndrome were also detected with one eye papilloedema 
and other eye optic atrophy, etiology being parietal SOL and 
sphenoid ridge meningioma. 
 This was similar to Subramanian et al study11. 
10. CT findings: 
 CT was normal in 53.4% of  which 25 patients had 
Idiopathic intra cranial hypertension (33%), 9 had malignant 
hypertension (12%), 3 had PIH (4%), 2 had iron deficiency 
anaemia (2.6%), SOL constitute 33.3% 
 4 out of the 25 Idiopathic intra cranial hypertension 
patients had no complaints and papilloedema was detected on 
routine ophthalmic examination (15) 
11. Etiology: 
 Idiopathic intra cranial hypertension was found to be the 
commonest cause of papilloedema in my study.  13 patients with 
Idiopathic intra cranial hypertension were medically managed 
and showed drastic improvement in symptoms. 
 2 patients underwent  lumbar puncture to reduce the CSF 
pressure.  One was of unknown cause presenting with severe 
visual loss,  the other was a steroid   induced BIH, presenting 
with severe head ache.  Treatment relieved their visual loss and 
head ache. 
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Tumours: 
 Out of the 23 patients with intra cranial tumour 32% were 
supra tentorial and 50% were infra tentorial tumours which is in 
concurrence with study (11) by Subramaniam et al. 
 Gliomas constituted 9.3% of the papilloedema patients,  
meningioma 6.6%, Neurocysticercosis 2.6%, CP angle tumour 
2.6% clival chordoma 1.3% (17) 
 5 cases were treated surgically by craniotomy and 
decompression, 2 cases treated with both surgery and 
radiotherapy.  6 cases died prior to surgery 2 cases referred to 
higher centre for further management.  10 cases were  lost to 
follow up. 
Anaemia: 
 2 cases of anaemia manifested with papilloedema.  
Papilloedema in iron deficiency anaemia is mainly due to 
cerebral ischaemia and cerebral edema and it is very rare.  This 
is in concurrence with study by V.Biocusse, N.Newman et al (19). 
TB meningitis: 
 TB meningitis occurred in 6.6% of cases.  They were 
treated with ATT and all showed improvement after treatment.  
This low incidence is as compared to Subramanian et al study 
can be explained by the MDT (Multi Drug Therapy) and early 
diagnosis by CT / MRI / Anti TB IgM availed in the recent times. 
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Malignant HT: 
 12% of the papilloedema patient had malignant  
hypertension, similar to Shelbure et al study12. 
Behcet syndrome: 
 One of the patient in my study was a case of Behcet 
syndrome with DVT on treatment which is in concurrence with a 
case report by Panir NM, Kansu T et al23 . 
Cortical Vein Thrombosis: 
 4 patients with Cortical Vein Thrombosis in my study 
presented with sudden, visual loss in both eye and multiple 
cranial nerve palsies26 . 
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CONCLUSION 
 
1. Papilloedema is most common in the 3rd decade of life and 
rare after 50 years of age.  There is a female 
preponderance. 
2. Headache is the commonest symptom and vomiting is rare 
according to my study. 
3. Poor vision at presentation and late detection of 
papilloedema are factors responsible for poor visual 
outcome. 
4. Symptoms of vomiting and diplopia are infrequent but 
important indicators of papilloedema. 
5. Enlarged blind spot is the commonest field defect. 
6. Idiopathic intra cranial hypertension was the commonest 
etiology for papilloedema in my study. 
7. Infra tentorial tumours are the commonest intra cranial 
space occupying lesions causing papilloedema. 
8. All patients visiting the ophthalmology department must 
have a fundus examination to detect papilloedema 
especially those presenting with headache. 
9. Behcet syndrome and iron deficiency anaemia have to be 
born in mind as rare but proven causes of papilloedema. 
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RECOMMENDATION & PREVENTIVE PROSPECTS 
 
1. All the patients  with headache should be evaluated 
ophthalmoscopically to look for papilloedema. 
 
2. Early diagnosis and prompt treatment may relieve  
symptoms. 
 
3. In chronic cases papilloedema resolves into optic atrophy 
and visual loss is the outcome.  So early treatment is 
necessary to retain vision. 
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PROFORMA 
 
Name  :    Age / Sex :  
IP / OP No :     Occupation: 
Address :    Contact No: 
 
1) PRESENTING COMPLAINTS:  
Headache / Nausea / Vomiting 
Visual Complaints :  
Diplopia / Transient Blurring of vision / photopsia / 
gradual loss of vision  
Neurological Complaints:  
Loss of consciousness / motor weakness / sphincter 
control / personality disturbance / Head Trauma / Seizures. 
ENT  Complaints :  
Speech / hearing problem / Nasal regurgitation / CSF 
rhinorrhea / Bleeding per ear / Tinnitus. 
2) DURATION OF ILLNESS 
3) PAST HISTORY 
 DM / HT / IHD / BA / TB / Thyroid Ds / Arthritis / 
Similar episodes. 
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4) PERSONAL HISTORY 
 Smoker / alcoholic / Veg / Non-veg / Exposure to pet 
animals  
Exposure to STD / Abortion – In female patients – Obstetric 
history – menstrual cycle, PIH. 
5) FAMILY HISTORY 
6) TREATMENT / DRUG HISTORY :  
Vit A / OCP / Nalidixic acid, steroids / Medical or Surgical 
/ ENT/Neck surgery. 
7) GENERAL EXAMINATION  
 Conscious /  Orientation / Nourishment / Anaemia  
Jaundice / clubbing / Generalised Lymphadenopathy / Pedal 
edema / Neurocutaneous markers / Congenital anomalies. 
8) SYSTEMIC EXAMINATION 
CVS  -    BP -   PR 
RS -  
P/A - 
CNS - 
OPHTHALMIC EXAMINATION 
Head posture 
Facial symmetry 
Exophthalmos / Enophthalmos  R.E  L.E 
Eye position 
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Eye lids 
Ocular movements 
Conjunctiva 
Cornea 
Anterior Chamber 
Iris 
Pupil 
 Size 
 Shape 
 Light reflex 
  Direct 
  Consensual 
 Near reflex 
Lens 
Anterior Vitreous phase  Posterior vitreous  
FUNDUS  Both Direct & Indirect 
 Media   R.E  L.E 
 Disc 
  Size 
  Shape 
  Margins 
  Colour 
  Cup: Disc ratio 
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  Lamina cribrosa 
 Vessels on the disc 
 Peripapillary region 
  Edema 
  Folds 
  Laminar separation 
  Hemorrhages 
  Others 
 Vessels 
  Sheathing 
  Pulsations 
  A:  V ratio 
 Periphery 
  Hemorrhages 
  Exudates 
  Others 
 Macula 
Fundus Diagnosis: 
Visual Acuity 
 Distant 
  Without correction 
  With correction 
 Nearvision 
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 Colour vision 
 Retinoscopy 
 Intraocular Tension 
 Gonioscopy 
 Visual Fields 
  Central   Peripheral 
 Diplopia Charting 
 Hess charting 
 
NEUROLOGICAL EXAMINATION 
Higher functions 
Cranial nerves    R.E  L.E 
Motor system 
Sensory system 
Cerebellar system 
Reflexes 
Cardiovascular system   Respiratory system
 Gastrointestinal system  
E.N.T.  Examination:   Endocrine system 
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PROVISIONAL DIAGNOSIS 
INVESTIGATIONS 
Hematology: 
 Hb%   TC   DC 
 ESR 
 RBC count  Platelet count    
Mantoux:   Blood VDRL  ELISA 
Blood sugar: Fasting  Post – prandial 
C.S.F analysis (if any) 
Urine – Albumin  Sugar Motion-Ova Cyst 
Radiological examination: 
X-Ray Skull, Orbit, Chest,   
CT Scan   
M.R.I. Scan 
Ultra sound Examination 
Fundus Fluorescin Angiography 
FINAL DIAGNOSIS 
Treatment   
Medical    
Surgical 
FOLLOW UP. 
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MASTER CHART 
 
 
 
S.No Age Sex 
Head 
ache    
Nausea 
& 
Vomiting Duration 
Past H/o
TB   BA 
RAPD
 
Cranial nerve 
involvement 
  
  
   
V/A 
 Fundus   CT Field  Etiology 
                 III IV V VI 
Hemi 
plegia 
 
      
1 26 F Y Y 3 days Y N N N N N N 6/6    Chronic N EBS IIH 
2 42 M Y N 2 weeks N N N N N N N 6/6    Early Mass EBS SOL 
3 55 F Y Y 10 days N N N N N N N 6/6    Early Mass EBS SOL 
4 45 M Y N 3 months N N N N N N N 6/6    Established Mass N SOL 
5 5 M Y Y 3 months N N N N N N N 6/6    Early Mass EBS SOL 
6 13 F Y Y 15 days N N N N N N N 6/18  Early Mass EBS SOL 
7 30 F Y Y 15 days N N N N N N N 6/6    Established Mass EBS SOL 
8 25 F Y N 2 weeks N Y N N N Y Y 6/6    Established N EBS TBM 
9 30 M Y N 1 week N N N N N N N 6/6    Early N EBS IIH 
10 15 F Y Y 3 months N N Y Y Y Y N 6/24  Established Mass EBS SOL 
11 40 M N N 20 days N N N N N N N 6/60 Early Mass EBS SOL
12 20 F Y N 1 week N N N N N N N 6/6   Early N EBS ADEM
13 29 F Y Y 15 days N N N N N N N 6/6    Chronic N EBS Anaemia 
14 16 M N Y 2 weeks N N N N N N N 6/6    Early N EBS IIH 
15 23 F Y Y 1 month N N N N N N N 6/6    Early N EBS PIH 
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MASTER CHART 
 
 
S.No Age Sex 
Head 
ache    
Nausea 
& 
Vomiting Duration 
Past H/o
TB   BA 
RAPD
 
Cranial nerve 
involvement 
  
  
   V/A Fundus   CT Field  Etiology 
          III IV V VI 
Hemi 
plegia 
 
16 34 F Y Y 6 months N N N N N N N 6/6  Established N EBS IIH 
17 54 F Y Y 1 week N N N N N N N 6/36 Early Mass EBS SOL 
18 24 F Y Y 1 week  N N N N N N N 6/6  Early N    EBS IIH 
19 13 F Y N 1 week   N N N N N N N 6/6  Early  N    PFC IIH 
20 24 F Y Y 2 week   N N N N N N N 6/6   Early N    PFC PIH 
21 57 M Y N 2 months N N Y Y N N Y 6/6  Established N    EBS IIH 
22 45 F Y N 6 months N N N N N N N 6/6  Early N    PFC IIH 
23 32 F Y Y 1 week N N N N N N N 6/6  Early N N    IIH 
24 39 F Y N 6 days N N N N N N N 6/6   Early Mass PFC SOL 
25 13 F Y Y 1 month  N N N N N N N 6/6   Eearly  Mass PFC SOL 
26 50 F Y Y 4 months N N N N N N N 6/6   Established N    PFC IIH 
27 30 F Y N 6 months N N N N N N N 6/6  Chronic N PFC IIH
28 50 M N N 6 months N N Y Y Y N Y CFCF Atrophic DLV NAT SOL    
29 28 F Y Y 4 months N N N N N N N 6/6  Early N EBS IIH 
30 20 F Y Y 10 days N N N N N N N 6/6  Established N N   IIH 
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MASTER CHART 
 
 
 
 
 
 
 
S.No Age Sex 
Head 
ache    
Nausea 
& 
Vomiting Duration 
Past H/o
TB   BA 
RAPD
 
Cranial nerve 
involvement 
  
  
   V/A Fundus   CT Field  Etiology 
          III IV V VI 
Hemi 
Plegia 
 
31 30 F Y N 1 month Y N N N N Y Y 6/6  Chronic Mass EBS TBM 
32 26 M N N 4 years N N N N N N N 1/60 Atrophic Mass NAT SOL 
33 14 F Y N 2 weeks N N N N N Y Y 6/6  Established N    PFC TBM 
34 25 F Y N 2 weeks  N N N N N N N 6/6  Established N    N    IIH 
35 5  M Y N 2 months N N N N N N N 6/6  Established N    N    IIH 
36 28 F Y N 2 weeks  N N N N N N N 6/6  Established AVM N    AVM 
37 22 M Y N 10 days N N N N N N N 6/6  Early N    EBS HT  
38 32 F Y N 1 year N N N N N N N 6/60 Chronic Mass PFC  SOL 
39 43 M Y N 3 days N N N N N N N 6/6  Early N    N    IIH 
40 24 M Y N 2 days  N N N N N N N 6/6  Eearly  N     PFC HT  
41 55 M Y N 3 month N N N N N Y Y 6/36 Established N    N    IIH 
42 43 M N N 1 week N N N N N N N 6/6 Early N PFC HT 
43 27 F N N 1 week N N N N N N N 6/6  Early N PFC PIH    
44 9  F Y N 10 days N N N N N N N 6/6  Established N PFC HT 
45 29 M Y Y 1 week N N N N N N N 6/6  Established N EBS CVT 
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MASTER CHART 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
S.No Age Sex 
Head 
ache    
Nausea 
& 
Vomiting Duration 
Past H/o
TB   BA 
RAPD
 
Cranial nerve 
involvement 
  
  
   
V/A 
 Fundus   CT Field  Etiology 
                 III IV V VI 
Hemi 
plegia 
 
      
46 22 M Y N 2 weeks N N N N N N N 6/6  Established N    N   Behcet 
47 58 M Y N 2 weeks N N N N N N N 6/6  Established N    EBS HT  
48 41 M Y N 6 days  N N N N N N N 6/6  Early N    PFC IIH 
49 40 F Y N 1 month  N Y N N N Y Y 1/60 Atrophic Mass NAT  SOL 
50 42 M N N 1 week   N N N N N N N CFCF Established N    Others IIH 
51 45 F Y Y 2 weeks  N N N N N N N 6/6  Established N    EBS  HT   
52 25 F Y N 15 days N N N N N N N 6/6  Established N    N   Anaemia 
53 13 F Y N 1 week N N N N N Y N 6/6  Early   N    N    IIH 
54 24 F Y Y 2 weeks N N N N N N N 6/6  Early N    N    HT  
55 50 M Y N 3 months N N N N N N N 1/60 Atrophic DLV  NAT SOL 
56 47 F Y N 3 months Y N Y Y N Y N 6/60 Established Mass PFC SOL
57 27 F Y N 6 months N N N N N N N HM  Chronic Mass NAT SOL
58 54 M Y Y 45 days N N N N N Y Y 6/6  Early N N    TBM    
59 50 F Y Y 6 month N N N N N N N 6/6  Chronic N N    IIH 
60 30 M N N 2 months N N N N N N N 1/60 Early Mass NAT SOL 
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MASTER CHART 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
HM  – Hand movement      Early   - Early papilloedema   EBS – Enlarged Blind Spot 
CFCF  – Counting finger close to face  Established  - Established papilloedema   NAT – Not Able to Test  
IIH  – Idiopathic Intra cranial Hypertension Chronic - Chronic papilloedema  SDH – Sub Dural  Haemorrhage  
  SOL  – Space Occupying lesion   Atrophic - Atrophic papilloedema 
  TBM  – Tuberculous Meningitis   DVT   - Dural Venous Thrombosis  
S.No Age Sex 
Head 
ache    
Nausea 
& 
Vomiting Duration 
Past H/o
TB   BA 
RAPD
 
Cranial nerve 
involvement 
  
  
   
V/A 
 Fundus   CT Field  Etiology 
                 III IV V VI 
Hemi 
Plegia 
 
      
61 40 M Y Y 25 days Y N N N N N N 6/6  Chronic SOL EBS SOL 
62 28 F Y Y 25 days N Fixed Y Y N Y Y 4/60 Chronic  DVT NAT DVT 
63 50 F Y Y 2 years N N N N N Y N 6/6  Chronic  SOL N    SOL 
64 84 M Y Y 45 days  N N N N N N N 6/6  Established SOL N    HT 
65 30 M Y Y 60 days HIV +ve N N N N N N 1/60 Chronic Mass NAT SOL
66 29 M Y Y 1 week N N N N N Y Y 6/6 Established N EBS TBM
67 38 M Y Y 1 week HIV +ve N N N N N N 6/6  Established N    EBS IIH 
68 60 M Y Y 10 days N N N N N N N 6/6  Established SDH EBS  IIH 
69 25 F Y Y 1 week N N N N N Y Y 6/6  Early   CVT  EBS  DVT 
70 28 F Y Y 20 days N Y Y Y N Y N HM   Chronic DVT  NAT DVT 
71 24 M Y N 1 week  N N N N N N N 6/6  Early N    N    IIH 
72 40 F Y N 2 days N N N N N N N 6/6  Chronic SOL N    SOL 
73 35 M Y N 2 months N N N N N N N 3/60 Chronic SOL N    SOL   
74 40 M Y N 25 days N N N N N N N 6/6  Established N EBS IIH 
75 50 F Y Y 1 month N N N N N N N 6/6  Chronic SOL PFC SOL 
